Log in to save to my catalogue

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robus...

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robus...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d10db68c1aa4ab699f45680ebe496a8

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models

About this item

Full title

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1227-A1227

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundSTING is an innate immune pathway that detects intracellular DNA from foreign pathogens as well as stressed or tumor cells and activates a proinflammatory, type I interferon (IFN) response.1 STING activation is critical for mounting anti-viral immunity, and recent advances suggest this pathway can be co-opted to drive an anti-tumor immune...

Alternative Titles

Full title

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3d10db68c1aa4ab699f45680ebe496a8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3d10db68c1aa4ab699f45680ebe496a8

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.1114

How to access this item